We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Adagene Inc | NASDAQ:ADAG | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.26 | 2.26 | 2.80 | 0 | 11:52:21 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K/A
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of November 2024
Commission File Number: 001-39997
Adagene Inc.
4F, Building C14, No. 218
Xinghu Street, Suzhou Industrial Park
Suzhou, Jiangsu Province, 215123
People’s Republic of China
+86-512-8777-3632
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
EXPLANATORY NOTE AND INCORPORATION BY REFERENCE
Adagene Inc. (the “Company”) is amending its report on Form 6-K furnished to the Securities and Exchange Commission on July 25, 2024 (File/Film Number: 001-39997/241142065) (the “Original 6-K”) in order to re-file and replace the Original 6-K. This Form 6-K/A is being furnished solely to correct a typographical error in the signature page to the Original 6-K. All other information included in the Original 6-K remains unchanged.
This report on Form 6-K/A shall be deemed to be incorporated by reference into the registration statements on Form F-3 (File No. 333-264486) and Form S-8 (File No. 333-255250) of the Company (including any prospectuses forming a part of such registration statements), and shall be a part thereof from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Adagene Inc. | ||
By: | /s/ Peter Luo | |
Name: | Peter Luo | |
Title: | Chief Executive Officer | |
Date: November 7, 2024 |
EXHIBIT INDEX
Exhibit | Description | |
99.1 | Press release tilted “Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update” (incorporated by reference to Exhibit 99.1 from the current report on Form 6-K (File/Film Number: 001-39997/241142065) on July 25, 2024)) | |
99.2 | Unaudited Interim Condensed Consolidated Financial Statements for the six months ended June 30, 2023 and 2024 (incorporated by reference to Exhibit 99.2 from the current report on Form 6-K (File/Film Number: 001-39997/241142065) on July 25, 2024)) | |
101.INS | Inline XBRL Instance Document – this instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
101.SCH | Inline XBRL Taxonomy Extension Schema | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase | |
104 | Cover Page Interactive Data File (embedded within the Inline IXBRL document) |
1 Year Adagene Chart |
1 Month Adagene Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions